Hofseth Biocare ASA
OSE:HBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Hofseth Biocare ASA (HBC) under the Base Case is 2.711 NOK per share.
Compared with the current market price of 1.115 NOK, the stock appears
Undervalued by 59% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -53% last year to 1.3% by 2033. Revenue grows about 21% a year over the next five years, below its five-year pace of 30%. The forecast years subtract value, so the estimate rests entirely on the years after 2033.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Hofseth Biocare ASA Does
Hofseth Biocare ASA is a Norwegian life-sciences company that turns salmon side streams into specialty ingredients. It processes fish raw material into products such as fish oils, protein hydrolysates, and calcium-rich ingredients that can be used in nutrition and health-focused products. In simple terms, it takes material that would otherwise be low-value by-product and upgrades it into higher-value ingredients.
- Headquarters
- Norway NO
- Employees
- 81
- IPO date
- Dec 2, 2011
Revenue & Expenses Breakdown
Hofseth Biocare ASA
Earnings Waterfall
Hofseth Biocare ASA
What is the Intrinsic Value of one HBC stock?
The intrinsic value for Hofseth Biocare ASA (HBC) under the Base Case is 2.711 NOK.
Is HBC stock undervalued or overvalued?
Compared with the current market price of 1.115 NOK, the stock appears Undervalued by 59% .
